The board of directors of NeuPath Health Inc. announced that Grant Connelly has agreed to step down as the Chief Executive Officer. Mr. Connelly will depart NeuPath on or before August 19, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.205 CAD | +5.13% | +5.13% | +10.81% |
May. 16 | NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.81% | 8.43M | |
+23.43% | 86.96B | |
-23.75% | 75.65B | |
+0.49% | 26.97B | |
+5.88% | 17.89B | |
-13.25% | 16.58B | |
+2.86% | 15.73B | |
+76.05% | 13.01B | |
+78.96% | 12.92B | |
+37.57% | 12.57B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. Announces Grant Connelly Step Down from Chief Executive Officer, on or Before August 19, 2022